Contact Us
Drug Search Results
Using advanced filters...
Advanced Search [+]

VSJ-110

Alternative Names: vsj-110, vsj110, vsj 110
Latest Update: 2024-03-06
Latest Update Note: Clinical Trial Update

Product Description

For Treatment of Allergic Conjunctivitis Using an Allergen Challenge Model (Sourced from: https://clinicaltrials.gov/ct2/show/NCT04622345)

Mechanisms of Action: CFTR Activator

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: N/A

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Cycle
Company Location:
Company CEO:
Additional Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for VSJ-110

Countries in Clinic: United States

Active Clinical Trial Count: 1

Highest Development Phases

Phase 2: Dry Eye Syndromes|Keratoconjunctivitis Sicca

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success
VP-VSJ-110-2201

P2

Recruiting

Dry Eye Syndromes|Keratoconjunctivitis Sicca

2024-07-01

24%

Recent News Events

Date

Type

Title

10/26/2020

News Article

 Vanda Pharmaceuticals Receives FDA Approval to Proceed with Investigational New Drug VSJ-110 for Allergic Conjunctivitis

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you've used PRYZM, we hope you're able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions